Bio Impact Capital LLC Portfolio Holdings

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024

Bio Impact Capital LLC has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $641 Million distributed in 43 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $128M, Insmed Inc with a value of $44.9M, Olema Pharmaceuticals, Inc. with a value of $32M, Avidity Biosciences, Inc. with a value of $31.6M, and Crinetics Pharmaceuticals, Inc. with a value of $26.9M.

Examining the 13F form we can see an increase of $18.3M in the current position value, from $623M to 641M.

Bio Impact Capital LLC is based out at Cambridge, MA

Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $641 Million
Healthcare: $641 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$601M
$128 Million 19.97% of portfolio
7,648,268
Q3 2021 Reduced 3.36%
$9.81B
$44.9 Million 7.01% of portfolio
615,391
Q2 2024 Added 15.94%
$413M
$32 Million 4.99% of portfolio
2,680,596
Q3 2024 Added 0.97%
$2.15B
$31.6 Million 4.94% of portfolio
688,975
Q3 2024 Added 451.18%
$3.08B
$26.9 Million 4.19% of portfolio
525,845
Q3 2024 Reduced 5.62%
$1.99B
$24.5 Million 3.82% of portfolio
917,166
Q3 2024 Added 23.83%
$1.43B
$22.6 Million 3.53% of portfolio
2,406,714
Q3 2024 Added 1.69%
$16.5B
$22.5 Million 3.51% of portfolio
177,099
Q3 2024 Added 1.31%
$1.09B
$19.7 Million 3.07% of portfolio
1,066,373
Q3 2024 New
$1.7B
$19.2 Million 3.0% of portfolio
492,723
Q3 2024 Added 0.03%
$3.33B
$18.3 Million 2.86% of portfolio
329,733
Q3 2024 Reduced 13.35%
$304M
$17.8 Million 2.78% of portfolio
1,745,943
Q1 2022 Reduced 5.35%
$2.01B
$17.6 Million 2.75% of portfolio
349,063
Q3 2024 Added 1.7%
$6.16B
$16.5 Million 2.57% of portfolio
150,182
Q3 2024 Added 0.12%
$5.45B
$15.4 Million 2.4% of portfolio
72,395
Q3 2024 Added 1.7%
$561M
$14.4 Million 2.25% of portfolio
2,033,041
Q3 2024 Added 59.52%
$4.54B
$13.2 Million 2.06% of portfolio
291,391
Q3 2024 Added 0.69%
$3.63B
$11.4 Million 1.79% of portfolio
499,170
Q3 2024 Reduced 0.17%
$1.49B
$11.3 Million 1.76% of portfolio
392,544
Q3 2024 Added 1.7%
$253M
$10.4 Million 1.62% of portfolio
896,915
Q3 2024 Added 1.7%
$168M
$10.4 Million 1.62% of portfolio
5,641,894
Q3 2024 Added 12.72%
$143M
$9.8 Million 1.53% of portfolio
2,832,064
Q3 2024 Reduced 6.94%
$246M
$8.95 Million 1.4% of portfolio
1,796,750
Q3 2024 New
$1.67B
$7.77 Million 1.21% of portfolio
171,105
Q3 2024 New
$3.95B
$7.66 Million 1.19% of portfolio
120,982
Q3 2024 Added 1.7%
$2.62B
$6.52 Million 1.02% of portfolio
165,800
Q3 2024 New
$476M
$5.89 Million 0.92% of portfolio
479,452
Q3 2024 New
$134M
$5.64 Million 0.88% of portfolio
1,639,849
Q3 2021 Reduced 2.16%
$1.2B
$5.5 Million 0.86% of portfolio
267,557
Q3 2024 Reduced 39.67%
$209M
$5.38 Million 0.84% of portfolio
1,465,801
Q3 2024 Added 1.09%
$166M
$5.14 Million 0.8% of portfolio
1,538,517
Q3 2024 Added 1.88%
$1.33B
$5.12 Million 0.8% of portfolio
624,471
Q3 2024 New
$495M
$5.09 Million 0.79% of portfolio
219,508
Q3 2024 New
$57.9M
$5.06 Million 0.79% of portfolio
2,388,011
Q2 2021 New
$118M
$4.84 Million 0.76% of portfolio
5,095,912
Q2 2023 New
$67.6M
$4.39 Million 0.68% of portfolio
2,409,862
Q3 2024 Added 10.5%
$3.73B
$3.33 Million 0.52% of portfolio
89,715
Q3 2024 New
$441M
$2.44 Million 0.38% of portfolio
330,000
Q3 2024 Reduced 70.58%
$432M
$524,000 0.08% of portfolio
50,000
Q3 2024 Reduced 91.02%
Cartesian Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 142.37%
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 2.0%
Solid Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 43
  • Current Value $641 Million
  • Prior Value $623 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 10 stocks
  • Additional Purchases 20 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email